Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Meilleure Health International Industry Group Limited ( (HK:2327) ) has provided an update.
Meilleure Health International Industry Group Limited has announced the current composition of its board of directors and the allocation of roles across its four key board committees. The Board is led by co-chairmen Mr. Zhou Xuzhou and Dr. Zeng Wentao, with Ms. Zhou Wen Chuan serving as vice-chairman and chief executive officer, alongside one non-executive and three independent non-executive directors, who collectively chair and sit on the audit, remuneration, nomination and strategic committees. This updated governance structure clarifies responsibilities and oversight across core board functions, reinforcing the company’s corporate governance framework and potentially providing greater transparency and assurance to shareholders and other stakeholders.
The most recent analyst rating on (HK:2327) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Meilleure Health International Industry Group Limited stock, see the HK:2327 Stock Forecast page.
More about Meilleure Health International Industry Group Limited
Meilleure Health International Industry Group Limited is a Bermuda-incorporated company listed in Hong Kong (Stock Code: 2327). It operates as an investment holding company with a focus on the health-related industry, overseen by a board comprising executive, non-executive and independent non-executive directors who guide its strategic and governance functions.
Average Trading Volume: 2,476,516
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.11B
For an in-depth examination of 2327 stock, go to TipRanks’ Overview page.